Informação sobre produto
- CML
- (2S)-2-Amino-6-(carboxymethylamino)hexanoic acid
- <span class="text-smallcaps">L</span>-Lysine, N<sup>6</sup>-(carboxymethyl)-
- L-Lysine,N6-(carboxymethyl)-
- Lysine, N<sup>6</sup>-(carboxymethyl)-, <span class="text-smallcaps">L</span>-
- Lysine,N6-(carboxymethyl)-, L- (8CI)
- N-(3-chloro-4-fluorophenyl)-2-[(2-chlorophenyl)sulfanyl]acetamide
- N6-(1-Carboxymethyl)-L-lysine
- N6-(Carboxymethyl)lysine
- N<sup>6</sup>-(Carboxymethyl)-<span class="text-smallcaps">L</span>-lysine
- Ver mais sinónimos
- N<sup>6</sup>-(Carboxymethyl)lysine
- N<sup>ε</sup>-(Carboxymethyl)lysine
- Ne-(Carboxymethyl)lysine
- e-(Carboxymethyl)lysine
- N6-(Carboxymethyl)-L-lysine
- Lysine, N6-(carboxymethyl)-, L-
Nε-(1-Carboxymethyl)-L-lysine (CML), an advanced glycation end product (AGE), is formed through the oxidative modification of glycated proteins under conditions of oxidative stress.1,2,3 Its levels escalate with age, diabetes, cancer, vascular diseases, and various pathologies associated with oxidative stress.1,4,5 CML interacts with the membrane-bound receptor for AGEs (RAGE), initiating signaling via MAPKs and NF-κB pathways. Conversely, a truncated version of RAGE generates a soluble protein that sequesters CML, thereby diminishing this signaling.6,7
Propriedades químicas
Consulta técnica sobre: TM-T84435 Nε-(1-Carboxymethyl)-L-lysine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
